根据最终合并协议,Viewpoint的每一股已发行和流通股份将转换为获得Isoray 3.3212股的权利。Viewpoint股东将拥有Isoray完全稀释的流通股49%的股份。
$华海药业(SH600521)$ $华东医药(SZ000963...查看全文
$Isoray(ISR)$ DEF 14A Other definitive proxy statements Accession Number: 0001437749-21-024237 Act: 34 Size: 876 KB 网页链接
$Isoray(ISR)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001437749-21-024239 Act: 34 Size: 419 KB 网页链接
$Isoray(ISR)$ 424B5 Prospectus [Rule 424(b)(5)] Accession Number: 0001437749-21-023092 Act: 33 Size: 1 MB 网页链接
$Isoray(ISR)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001437749-21-022693 Act: 34 Size: 6 MB 网页链接
$Isoray(ISR)$ 8-K Current report, items 2.02, 8.01, and 9.01 Accession Number: 0001437749-21-022490 Act: 34 Size: 191 KB 网页链接
$Isoray(ISR)$ 8-K Current report, items 1.01 and 9.01 Accession Number: 0001437749-21-022207 Act: 34 Size: 66 KB 网页链接
$Isoray(ISR)$ 8-K Current report, items 1.01 and 9.01 Accession Number: 0001437749-21-020999 Act: 34 Size: 27 KB 网页链接
$Isoray(ISR)$ 8-K Current report, items 1.01 and 9.01 Accession Number: 0001437749-21-018363 Act: 34 Size: 30 KB 网页链接
$Isoray(ISR)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001437749-21-016451 Size: 5 KB 网页链接
$Isoray(ISR)$ 8-K Current report, items 1.01 and 9.01 Accession Number: 0001437749-21-014071 Act: 34 Size: 102 KB 网页链接